Skip to main content

Tag: cannabis

Molson Coors beers Molson Coors beers Molson Coors beers Molson Coors beers Molson Coors beers Molson Coors beers Molson Coors beers Molson Coors beers Molson Coors beers Molson Coors beers Molson Coors beers Molson Coors beers Molson Coors beers Molson Coors beers Molson Coors beers Molson Coors beers Molson Coors beers Molson Coors beers Molson Coors beers Molson Coors beers Molson Coors beers Molson Coors beers Molson Coors beers Molson Coors beers Molson Coors beers Molson Coors beers Molson Coors beers Molson Coors beers Molson Coors beers Molson Coors beers Molson Coors beers Molson Coors beers Molson Coors beers Molson Coors beers Molson Coors beers Molson Coors beers Molson Coors beers Molson Coors beers Molson Coors beers Molson Coors beers Molson Coors beers Molson Coors beers Molson Coors beers Molson Coors beers Molson Coors beers Molson Coors beers Molson Coors beers Molson Coors beers Molson Coors beers Molson Coors beers Molson Coors beers Molson Coors beers Molson Coors beers Molson Coors beers Molson Coors beers Molson Coors beers Molson Coors beers Molson Coors beers Molson Coors beers Molson Coors beers Molson Coors beers Molson Coors beers Molson Coors beers Molson Coors beers Molson Coors beers Molson Coors beers Molson Coors beers Molson Coors beers Molson Coors beers Molson Coors beers Molson Coors beers Molson Coors beers Molson Coors beers Molson Coors beers Molson Coors beers Molson Coors beers Molson Coors beers Molson Coors beers Molson Coors beers Molson Coors beers Molson Coors beers Molson Coors beers Molson Coors beers Molson Coors beers Molson Coors beers Molson Coors beers Molson Coors beers Molson Coors beers Molson Coors beers Molson Coors beers Molson Coors beers Molson Coors beers Molson Coors beers Molson Coors beers Molson Coors beers Molson Coors beers Molson Coors beers Molson Coors beers Molson Coors beers Molson Coors beers Molson Coors beers Molson Coors beers Molson Coors beers Molson Coors beers Molson Coors beers Molson Coors beers Molson Coors beers Molson Coors beers Molson Coors beers Molson Coors beers Molson Coors beers Molson Coors beers Molson Coors beers Molson Coors beers Molson Coors beers Molson Coors beers Molson Coors beers Molson Coors beers Molson Coors beers Molson Coors beers Molson Coors beers Molson Coors beers Molson Coors beers Molson Coors beers

Molson Coors to Brew Cannabis Drinks in Canada, CBD Versions in the U.S.

Written by Anthony Johnson on . Posted in Business, Vancouver.

It was big news when Molson Coors Brewing Company announced that it was forging a partnership to brew non-alcoholic cannabis drinks in Canada, but it shouldn’t have been surprising. Alcohol giant Constellation Brands had already invested heavily in the cannabis industry and it shouldn’t shock anyone that big companies, particularly those involved with alcohol and tobacco, will be looking to join a multi-billion dollar market, especially when the new market cuts into their sales.

Molson Coors’ CEO expects that cannabis beverages will be a $3 billion sector in Canada, and the company has warned shareholders that legal cannabis is a threat to beer companies’ profit margins. The North American beer giant plans to sell a variety of cannabis drinks in accordance with Canada’s new regulations, starting on December 16th, the earliest date possible, before moving into the United States, with a line of CBD beverages. Bloomberg reported:

The maker of Coors Light has partnered with Gatineau, Quebec-based Hexo Corp. to make a variety of non-alcoholic, cannabis-infused drinks for the Canadian market. The joint venture, called Truss, will have “lots of different beverages” for sale on Dec. 16, when the beverages become legal in Canada, said Jay McMillan, Hexo’s vice president of strategic development.

***

Truss plans to offer everything from water to a “beer-like product” and maybe even hot beverages. It has flexible production lines so it can pivot if one type of beverage isn’t selling, he said.

It’s also looking at selling CBD-infused beverages in the U.S., which legalized the non-intoxicating substance late last year, with the goal of having products in eight states by 2020.

While the entry of big alcohol companies into the industry is likely good for consumers who want  a multitude of options to best suit their needs and lifestyle, it also provides an opportunity for smaller companies to find their niche. In many ways Molson Coors will serve as a research department for competitors as they put different types of beverages up for sale. After they find products that work, other companies can follow suit and find an avenue that works for them, such as producing and marketing a craft cannabis version, giving consumers the opportunity to support mom-and-pops. It will be very interesting in mid-December when cannabis beverages and other products hit the shelves and to see how the market shakes out over time.

The International Cannabis Business Conference in Vancouver this September 15-16 is the best place to learn the latest about Canada’s regulations and market, and to network with top investors and entrepreneurs. Don’t miss your opportunity, be sure to purchase early bird tickets by August 21st. 

Cannabis plant Cannabis plant Cannabis plant Cannabis plant Cannabis plant Cannabis plant Cannabis plant Cannabis plant Cannabis plant Cannabis plant Cannabis plant Cannabis plant Cannabis plant Cannabis plant Cannabis plant Cannabis plant Cannabis plant Cannabis plant Cannabis plant Cannabis plant Cannabis plant Cannabis plant Cannabis plant Cannabis plant Cannabis plant Cannabis plant Cannabis plant Cannabis plant Cannabis plant Cannabis plant Cannabis plant Cannabis plant Cannabis plant Cannabis plant Cannabis plant Cannabis plant Cannabis plant Cannabis plant Cannabis plant Cannabis plant Cannabis plant Cannabis plant Cannabis plant Cannabis plant Cannabis plant Cannabis plant Cannabis plant Cannabis plant Cannabis plant Cannabis plant Cannabis plant Cannabis plant Cannabis plant Cannabis plant Cannabis plant Cannabis plant Cannabis plant Cannabis plant Cannabis plant Cannabis plant Cannabis plant Cannabis plant Cannabis plant Cannabis plant Cannabis plant Cannabis plant Cannabis plant Cannabis plant Cannabis plant Cannabis plant Cannabis plant Cannabis plant Cannabis plant Cannabis plant Cannabis plant Cannabis plant Cannabis plant Cannabis plant Cannabis plant Cannabis plant Cannabis plant Cannabis plant Cannabis plant Cannabis plant Cannabis plant Cannabis plant Cannabis plant Cannabis plant Cannabis plant Cannabis plant Cannabis plant Cannabis plant Cannabis plant Cannabis plant Cannabis plant Cannabis plant Cannabis plant Cannabis plant Cannabis plant Cannabis plant Cannabis plant Cannabis plant Cannabis plant Cannabis plant Cannabis plant Cannabis plant

First German Cannabis Cultivation Bids Announced!

Written by Anthony Johnson on . Posted in Uncategorized.

The German medical cannabis system has been an innovative pioneer in a few respects, helping thousands of patients get access to tested medicinal cannabis that is covered by their insurance programs. However, regulatory burdens and the lack of domestic cultivation have hindered the program, increasing prices and decreasing the availability of strains and products. The German government has been accepting domestic cultivation applications in a process that has been complicated and shrouded in secrecy. Applicants could not even speak about applying or their bid would be hindered, as was discussed at the recent International Cannabis Business Conference in Berlin. Last week, Germany took a big step forward announcing three companies that have been selected for licenses, pending some issues still left to be worked out.

Our good friends at the German Cannabis Association (DHV) informed their supporters of this historic news in a newsletter (slight editing done due to Google translation issues):

One day after the International Cannabis Business Conference a message came in, with the judge not before 10:04. had expected. On Wednesday, the Federal Institute for Drugs and Medical Devices (BfArM) informed the 79 candidates who had applied for the cultivation of medicinal purposes in Germany. Accordingly, three companies, including the Canadian producer Aurora and Aphria and the German company Demecan should, (produce) the first medical cannabis in Germany grow(n). Originally, the Düsseldorf Higher Regional Court should adjudicate on an application that ran against the second licensing round on 04.10.2019. Given the ever-increasing numbers of patients but also advertised by the Cannabis Agency amount will not be enough and Germany will continue to be dependent on imports of medicinal purposes. Other licensing agreements are inevitable to meet as a medicine the increasing demand for cannabis from the perspective of the German Cannabis Association.

The sooner that domestic cultivation can occur, the better it will be for patients. The competition should be good for patients as Marguerite Arnold wrote for the Cannabis Industry Journal, importing into the country is also increasing, so prices should drop:

Several weeks ago, a Frankfurt-based distribution start-up announced that they had successfully imported cannabis into the country from Macedonian-based Nysk Holdings via Poland.

At the International Cannabis Business Conference in Berlin last weekend, Australian producers (for one) were also reporting a German demand for their product that was greater than they could fill. And there were many Israelis present for what is expected to be an official opening of their import ability by the third quarter of this year.

The bid itself is going to have a powerful impact on pricing in both the German and European market beyond that. It represents the first time in any country that a government has attempted to pre-negotiate prices for the drug as a narcotic beyond Israel and in this case, it will have at least regional implications.

While there are gonna be some more ups and downs, including lawsuits and bureaucratic wrangling, but Germany moving forward with domestic cultivation licenses is a great step forward for patients and the German cannabis industry. What happens in Germany ripples across the European continent and beyond, and you can learn the latest about these bids and the greater European industry at the next International Cannabis Business Conference in Zurich, Switzerland, this May 15th-16th, in collaboration with CannaTrade (taking place the 17th-19th), get your early-bird tickets by April 24th to save.

Hemp Hemp Hemp Hemp Hemp Hemp Hemp Hemp Hemp Hemp Hemp Hemp Hemp Hemp Hemp Hemp Hemp Hemp Hemp Hemp Hemp Hemp Hemp Hemp Hemp Hemp Hemp Hemp Hemp Hemp Hemp Hemp Hemp Hemp Hemp Hemp Hemp Hemp Hemp Hemp Hemp Hemp Hemp Hemp Hemp Hemp Hemp Hemp Hemp Hemp Hemp Hemp Hemp Hemp Hemp Hemp Hemp Hemp Hemp Hemp Hemp Hemp Hemp Hemp Hemp Hemp Hemp Hemp Hemp Hemp Hemp Hemp Hemp Hemp Hemp Hemp Hemp Hemp Hemp Hemp Hemp Hemp Hemp Hemp Hemp Hemp Hemp Hemp Hemp Hemp Hemp Hemp Hemp Hemp Hemp Hemp Hemp Hemp Hemp Hemp Hemp Hemp Hemp Hemp Hemp Hemp

European Union Hemp Set to Increase THC Percentage

Written by Anthony Johnson on . Posted in Berlin, Business, international cannabis business conference zurich.

Cannabis and hemp are obviously intertwined in reality and politically. Cannabis and hemp are the same plant, but politically and regulatorily, hemp has been classified as basically low-THC cannabis, with allowable THC percentages varying depending upon jurisdictions. In Switzerland, where the International Cannabis Business Conference will be holding its next event in conjunction with the global hemp fair CannaTrade, low-THC cannabis can contain up to 1% THC and be legally sold. European hemp industry participants had hoped to get the European Union hemp THC percentage up to that 1%, but that is going to take a bit more time. In good news, progress is being made, albeit too slowly as allowable THC percentages are expected to increase within the EU in 2021, as Hemp Today reported:

The European Union could soon change the allowed legal THC level in approved hemp varieties from 0.2% to 0.3% after the European Parliament Committee on Agriculture and Rural Development recently approved a batch of proposals for post-2020 reforms to the EU’s Common Agriculture Policy (CAP).

CAP implements a system of agricultural subsidies and other programs supporting member nations. Introduced in 1962, the program has undergone constant reform and now also embraces rural development.

Increasing allowable THC levels in hemp varieties grown in the EU from 0.2% to 0.3% would return the EU to the limit that was valid up until 1999. While some had called for an increase to a full 1% THC, perhaps a smaller incremental increase was always more likely to be favored.

The pace of much-needed regulatory changes is often maddening, particularly to people with a long history advocating for cannabis and hemp legalization. It can be extremely frustrating to see people knowledgeable on the cannabis plant placed in charge of enforcement policies and combatting debunked Reefer Madness propaganda. Patience and persistence will remain a virtue in the cannabis and hemp industries as the times are a-changin’ and we can expect more and more positive reforms, until the industries are really booming over the next 5-10 years across Europe, North America, and much of the world.

If you want to learn the latest about the hemp and cannabis industries while networking with top investors, entrepreneurs, and advocates from across the globe, the International Cannabis Business Conference in Zurich this May 15th-16th is the place to be. After Zurich, stick around for CannaTrade, Switzerland’s premier hemp expo. Secure your early-bird Zurich tickets by April 24th to save $$$!